IONS Ionis Pharmaceuticals, Inc. | US4622221004
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | 9.345.597.440 | 12.457.585.378,21 | 12.919.048.760,92 | 10.541.643.085,55 |
| Enterprise Value | 9.978.178.560 | 14.325.158.378,21 | 14.611.300.760,92 | 11.692.793.085,55 |
| Trailing P/E | - | - | - | - |
| Forward P/E | -52,92 | - | - | - |
| Price to Sales | 8,83 | 11,77 | 13,69 | 14,24 |
| Price to Book | 19,09 | 25,35 | 26,41 | 17,06 |
| EV/Revenue | 9,43 | 13,54 | 15,48 | 15,79 |
| EV/EBITDA | -29,47 | - | - | - |